NCT03879694 2026-02-06Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine TumorsRoswell Park Cancer InstitutePhase 1 Completed19 enrolled
NCT00427349 2023-07-05AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine TumorsEastern Cooperative Oncology GroupPhase 2 Completed46 enrolled 7 charts